pharmaceutical investing Midatech Announces Interim Results from Proof of Concept Exploratory Study for its MTD201 Q-Octreotide Programme and Q-Sphera Microsphere Technology
Placement to Institutional and Sophisticated Investors, Appointment of Joint Broker,Issue of Equity & TVR
